Literature DB >> 19209032

Selective cytotoxic activity of the marine-derived batzelline compounds against pancreatic cancer cell lines.

Esther A Guzmán1, Jacob D Johnson, Megan K Carrier, Cara I Meyer, Tara P Pitts, Sarath P Gunasekera, Amy E Wright.   

Abstract

Pancreatic cancer is the fourth leading cause of cancer death in the United States. The prognosis of the disease is very negative, because the cancer will be usually metastasized by the time a patient manifests symptoms. Although combination therapy shows some promise, new drugs to treat the disease are needed. Given our interest in finding new therapies for pancreatic cancer, we sought to determine whether the known cytotoxic activity of the batzellines extended to pancreatic cancer cell lines. The batzellines are pyrroloiminoquinones alkaloids obtained from the deep-water Caribbean sponge Batzella sp (family Esperiopsidae, order Poecilosclerida). We show here that batzellines exhibit selective cytotoxicity towards the pancreatic cancer cell lines AsPC-1, Panc-1, BxPC-3, and MIA PaCa2 compared with the normal African green monkey kidney epithelial cell line Vero. The batzellines cause cytotoxicity by inducing cell cycle arrest that is mediated by their ability to intercalate into DNA and/or inhibit topoisomerase II activity. The cytotoxic abilities of isobatzellines A and C against pancreatic cancer cell lines, their low toxicity against normal cells, and their reported ability to be synthesized makes them interesting compounds with potential chemotherapeutic effects that may merit further research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19209032      PMCID: PMC3031457          DOI: 10.1097/CAD.0b013e32831fa39e

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  13 in total

Review 1.  From DNA damage to G2 arrest: the many roles of topoisomerase II.

Authors:  Annette K Larsen; Alexandre E Escargueil; Andrzej Skladanowski
Journal:  Prog Cell Cycle Res       Date:  2003

Review 2.  Current state of adjuvant therapy in resected pancreatic adenocarcinoma.

Authors:  Magnus Bergenfeldt; Maria Albertsson
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

3.  Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus Zyzzya.

Authors:  Marie-Geneviève Dijoux; Peter C Schnabel; Yali F Hallock; Jamie L Boswell; Tanya R Johnson; Jennifer A Wilson; Chris M Ireland; Rob van Soest; Michael R Boyd; Louis R Barrows; John H Cardellina
Journal:  Bioorg Med Chem       Date:  2005-11-01       Impact factor: 3.641

4.  Makaluvamines, marine natural products, are active anti-cancer agents and DNA topo II inhibitors.

Authors:  L R Barrows; D C Radisky; B R Copp; D S Swaffar; R A Kramer; R L Warters; C M Ireland
Journal:  Anticancer Drug Des       Date:  1993-10

5.  Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interaction.

Authors:  S S Matsumoto; H M Haughey; D M Schmehl; D A Venables; C M Ireland; J A Holden; L R Barrows
Journal:  Anticancer Drugs       Date:  1999-01       Impact factor: 2.248

6.  A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth.

Authors:  Junan Li; Jiuxiang Zhu; W Scott Melvin; Tanios S Bekaii-Saab; Ching-Shih Chen; Peter Muscarella
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

7.  Secobatzellines A and B, two new enzyme inhibitors from a deep-water Caribbean sponge of the genus Batzella.

Authors:  S P Gunasekera; P J McCarthy; R E Longley; S A Pomponi; A E Wright
Journal:  J Nat Prod       Date:  1999-08       Impact factor: 4.050

8.  Batzelline D and isobatzelline E from the indopacific sponge Zyzzya fuliginosa.

Authors:  Leng Chee Chang; Sarah Otero-Quintero; John N A Hooper; Carole A Bewley
Journal:  J Nat Prod       Date:  2002-05       Impact factor: 4.050

Review 9.  Pyrroloiminoquinone and related metabolites from marine sponges.

Authors:  Edith M Antunes; Brent R Copp; Michael T Davies-Coleman; Toufiek Samaai
Journal:  Nat Prod Rep       Date:  2005-01-04       Impact factor: 13.423

Review 10.  DNA topoisomerase II, genotoxicity, and cancer.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Mutat Res       Date:  2007-07-03       Impact factor: 2.433

View more
  15 in total

1.  The potential of achiral sponge-derived and synthetic bromoindoles as selective cytotoxins against PANC-1 tumor cells.

Authors:  Nicholas Lorig-Roach; Frances Hamkins-Indik; Tyler A Johnson; Karen Tenney; Frederick A Valeriote; Phillip Crews
Journal:  Tetrahedron       Date:  2017-11-14       Impact factor: 2.457

2.  Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.

Authors:  Scharri J Ezell; Haibo Li; Hongxia Xu; Xiangrong Zhang; Evrim Gurpinar; Xu Zhang; Elizabeth R Rayburn; Charnell I Sommers; Xinyi Yang; Sadanandan E Velu; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2010-07-13       Impact factor: 5.118

3.  Isolation, synthesis, and biological activity of aphrocallistin, an adenine-substituted bromotyramine metabolite from the Hexactinellida sponge Aphrocallistes beatrix.

Authors:  Amy E Wright; Gregory P Roth; Jennifer K Hoffman; Daniela B Divlianska; Diana Pechter; Susan H Sennett; Esther A Guzmán; Patricia Linley; Peter J McCarthy; Tara P Pitts; Shirley A Pomponi; John K Reed
Journal:  J Nat Prod       Date:  2009-06       Impact factor: 4.050

4.  Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.

Authors:  Esther A Guzmán; Qunli Xu; Tara P Pitts; Kaoru Ogawa Mitsuhashi; Cheryl Baker; Patricia A Linley; Judy Oestreicher; Karen Tendyke; Priscilla L Winder; Edward M Suh; Amy E Wright
Journal:  Int J Cancer       Date:  2016-07-19       Impact factor: 7.396

5.  Spongiatriol inhibits nuclear factor kappa B activation and induces apoptosis in pancreatic cancer cells.

Authors:  Esther Guzmán; Michael Maher; Alexis Temkin; Tara Pitts; Amy Wright
Journal:  Mar Drugs       Date:  2013-04-02       Impact factor: 5.118

6.  Inhibition of IL-8 secretion on BxPC-3 and MIA PaCa-2 cells and induction of cytotoxicity in pancreatic cancer cells with marine natural products.

Authors:  Esther A Guzmán; Dedra Harmody; Tara P Pitts; Brunilda Vera-Diaz; Priscilla L Winder; Yichao Yu; Amy E Wright
Journal:  Anticancer Drugs       Date:  2017-02       Impact factor: 2.389

7.  Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog.

Authors:  Xiangrong Zhang; Hongxia Xu; Xu Zhang; Sukesh Voruganti; Srinivasan Murugesan; Dwayaja H Nadkarni; Sadanandan E Velu; Ming-Hai Wang; Wei Wang; Ruiwen Zhang
Journal:  Mar Drugs       Date:  2012-05-23       Impact factor: 6.085

Review 8.  Batzella, Crambe and Monanchora: Highly Prolific Marine Sponge Genera Yielding Compounds with Potential Applications for Cancer and Other Therapeutic Areas.

Authors:  Amr El-Demerdash; Atanas G Atanasov; Anupam Bishayee; Mamdouh Abdel-Mogib; John N A Hooper; Ali Al-Mourabit
Journal:  Nutrients       Date:  2018-01-02       Impact factor: 5.717

Review 9.  Development of Marine-Derived Compounds for Cancer Therapy.

Authors:  Weimin Zuo; Hang Fai Kwok
Journal:  Mar Drugs       Date:  2021-06-15       Impact factor: 5.118

10.  The marine natural product manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells.

Authors:  Georgios Kallifatidis; Dominic Hoepfner; Tiphaine Jaeg; Esther A Guzmán; Amy E Wright
Journal:  Mar Drugs       Date:  2013-09-17       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.